This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

WEB REGISTRATION CLOSES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Lauren Alfonse
Principal Scientist at Arbor Biotechnologies
Speaker

Profile

Lauren is currently a Principal Scientist at Arbor Biotechnologies where she leads a program pertaining to CRISPR nuclease discovery, development, and therapeutic target screening in collaboration with an external partner. Since joining Arbor in 2018 in its infancy, she has had the privilege of seeing company assets through from their earliest stages of discovery to pre-clinical relevancy. Prior to joining Arbor, Lauren worked in the Grgicak Laboratory at Boston University School of Medicine where she co-developed a software (now commercially licensed) that determines the probability distribution on the number of contributors to complex, forensic DNA evidentiary profiles. She received her B.S. from Boston College and her M.S. from Boston University School of Medicine.

Agenda Sessions

  • Identification and Engineering of ABR-004, A Compact, High-fidelity Nuclease for Therapeutic Gene Editing

    4:00pm